Plexus (NASDAQ:PLXS) Announces Q1 2027 Earnings Guidance

Plexus (NASDAQ:PLXS) updated its first quarter 2027 earnings guidance on Friday morning. The company provided EPS guidance of 2.460-2.620 for the period, compared to the consensus estimate of 2.340. The company issued revenue guidance of $1.4 billion-$1.5 billion, compared to the consensus revenue estimate of $1.4 billion.

Plexus Stock Performance

Shares of PLXS traded down $8.85 during trading hours on Friday, reaching $207.47. 66,661 shares of the company traded hands, compared to its average volume of 313,302. The company has a quick ratio of 0.72, a current ratio of 1.49 and a debt-to-equity ratio of 0.06. Plexus has a 12-month low of $132.03 and a 12-month high of $307.06. The stock has a market capitalization of $5.55 billion, a P/E ratio of 28.18 and a beta of 0.88. The business has a fifty day moving average price of $247.43 and a 200-day moving average price of $239.20.

Plexus (NASDAQ:PLXS) last posted its earnings results on Wednesday, October 28th. The technology company reported $2.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.55 by $0.29. The business had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.36 billion. Plexus had a net margin of 4.08% and a return on equity of 13.50%. The company’s revenue for the quarter was up 34.9% on a year-over-year basis. During the same period in the prior year, the company posted $2.14 EPS. Equities analysts anticipate that Plexus will post 8.55 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Sidoti raised shares of Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price target on the stock in a research note on Friday, July 31st. Needham & Company LLC reaffirmed a “buy” rating and issued a $310.00 price objective on shares of Plexus in a research note on Friday, August 14th. KeyCorp raised Plexus from a “sector weight” rating to an “overweight” rating and set a $300.00 price target for the company in a research report on Monday, September 21st. Weiss Ratings lowered shares of Plexus from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, October 23rd. Finally, Wall Street Zen lowered Plexus from a “buy” rating to a “hold” rating in a report on Saturday, October 24th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, Plexus has an average rating of “Buy” and a consensus target price of $276.86.

Insiders Place Their Bets

In other news, CEO Todd Kelsey sold 1,500 shares of the stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $250.98, for a total transaction of $376,470.00. Following the sale, the chief executive officer owned 65,888 shares in the company, valued at approximately $16,536,570.24. This represents a 2.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Karen Rapp sold 500 shares of the firm’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $240.87, for a total value of $120,435.00. Following the completion of the sale, the director owned 7,535 shares of the company’s stock, valued at approximately $1,814,955.45. This trade represents a 6.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 9,000 shares of company stock valued at $2,319,260. 1.78% of the stock is currently owned by corporate insiders.

Key Plexus News

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Quarterly results exceeded expectations. Plexus reported fiscal Q4 revenue of $1.427 billion, up 34.9% year over year, and adjusted EPS of $2.84 versus the roughly $2.55–$2.57 consensus. GAAP diluted EPS was $2.51, while adjusted operating margin reached 6.7%. Plexus fiscal fourth-quarter results
• Positive Sentiment: Growth momentum remains strong. Fiscal 2026 revenue reached a record $4.965 billion, up 23% year over year. Plexus won 36 manufacturing programs representing $290 million in potential annualized revenue at full ramp, and its qualified opportunity funnel expanded 33% to $4.9 billion.
• Positive Sentiment: First-quarter guidance was above consensus on adjusted earnings. Plexus projected fiscal Q1 2027 adjusted EPS of $2.46–$2.62, above the $2.34 analyst estimate, and revenue of approximately $1.41–$1.46 billion, broadly in line with expectations. Management also raised its long-term non-GAAP operating-margin goal to 6.5%–7.0% and expects mid- to high-teens revenue growth in fiscal 2027.
• Positive Sentiment: Shareholder returns could provide support. The company authorized a new $100 million fiscal 2027 share-repurchase program after buying back $85 million of stock in fiscal 2026. Management also expects at least $100 million of free cash flow in fiscal 2027.
• Neutral Sentiment: Technical sentiment has weakened after the stock fell below its 50-day and 200-day moving averages, although an earlier report noted PLXS had crossed above the 200-day average. Analysts cited in the provided coverage maintain targets well above the current trading level.
• Negative Sentiment: Cash generation and customer concentration remain risks. Fiscal-year free cash flow was negative $28.9 million because of heavy investment and working-capital needs, while the top 10 customers accounted for 56% of fourth-quarter revenue.
• Negative Sentiment: Insider selling may weigh on sentiment. Reported insider activity showed 26 sales and no purchases over the past six months, including substantial sales by CEO Todd Kelsey.

Plexus Company Profile

Plexus Corp. is an electronics manufacturing services company that helps customers design, develop, manufacture and service complex electronic products. The company provides an integrated product-realization process spanning engineering and design, supply-chain management, manufacturing, testing, logistics and aftermarket services.

Plexus supports original equipment manufacturers in industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.